The most common cancers in male relatives of BRCA2 carriers were lung (4.9%), esophageal (4.9%), and liver cancers (4.3%), followed by gastric (2.8%) and pancreatic (2.7%) cancers (Table 3). This evidence concerns the gene BRCA2 and cancer.